Characteristics | Primary prevention n = 756,953 | Secondary prevention n = 447,423 |
---|---|---|
Men, n (%) | 396,028 (52.3) | 274,891 (61.4) |
Age, mean | 63.7 ± 11.7 | 71.5 ± 9.5 |
Diabetes duration, mean years | 7.4 ± 7.1 | 10.5 ± 8.4 |
HbA1c, mean mmol/mol | 54.7 ± 14.6 | 55.5 ± 13.7 |
Diabetes medications, n (%) | 560,539 (74.4) | 350,387 (78.5) |
Antiplateletsa, n (%) | 171,114 (23.1) | 316,290 (72.1) |
Antihypertensives, n (%) | 508,907 (68.6) | 401,935 (90.9) |
Systolic blood pressure, mean mmHg | 137.2 ± 16.4 | 136.2 ± 16.9 |
Diastolic blood pressure, mean mmHg | 78.5 ± 9.6 | 74.9 ± 9.8 |
Total cholesterol, mean mmol/l | 5.4 ± 0.9 | 4.7 ± 1.0 |
LDL cholesterol, mean mmol/l | 3.4 ± 0.7 | 2.7 ± 0.8 |
HDL cholesterol, mean mmol/l | 1.3 ± 0.4 | 1.2 ± 0.3 |
Triglycerides, mean mmol/l | 1.8 ± 0.9 | 1.8 ± 0.9 |
eGFR, mean ml/min/1.73 m² | 85.6 ± 25.1 | 74.3 ± 25.0 |
Microalbuminuria, n (%) | 92,812 (17.8) | 77,698 (25.6) |
Macroalbuminuria, n (%) | 29,895 (5.7) | 35,005 (11.3) |
BMI, mean kg/m2 | 30.1 ± 5.4 | 29.7 ± 5.1 |
Physical activity < once a weekb, n (%) | 105,300 (24.2) | 87,486 (32.8) |
Smokingc, n (%) | 103,874 (17.1) | 49,766 (13.7) |